By contrast, a previous study showed that increased expression of HER4, one of the receptors of HB-EGF, was observed in thyroid papillary carcinomas compared to non-neoplastic thyroid tissues like HER1 (23). This evidence concerns the gene HBEGF and thyroid gland papillary carcinoma.